J. Goldman & Co’s GLOBEIMMUNE INC COM STK (DE) GBIM Stock Holding History

J. Goldman & Co’s Portfolio GBIM Stock Details GBIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-42,850	Closed	-$315K	–	380
2015 Q1	$315K	Buy	+42,850	New	+$310K	0.02%	257

Other funds holding GBIM

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

J. Goldman & Co's GBIM Position: Q2 2015 in Review

J. Goldman & Co sold out of GLOBEIMMUNE INC COM STK (DE) (GBIM) in Q2 2015, closing a stake of 42,850 shares — an estimated $315K sold.

J. Goldman & Co first reported a position in GBIM in Q1 2015 and held it in 1 quarter. The position peaked at $315K in Q1 2015. 9 funds tracked by Wall St. Rank hold GBIM as of Q2 2015.

J. Goldman & Co reported no remaining GLOBEIMMUNE INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
J. Goldman & Co sold 42,850 GLOBEIMMUNE INC COM STK (DE) shares in Q2 2015, an estimated $315K.
J. Goldman & Co first reported a position in GLOBEIMMUNE INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
J. Goldman & Co's GLOBEIMMUNE INC COM STK (DE) position peaked at $315K in Q1 2015.
9 funds tracked by Wall St. Rank held GLOBEIMMUNE INC COM STK (DE) as of Q2 2015.

Based on J. Goldman & Co's 13F filing for Q2 2015, filed 14 Aug 2015.